Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men
Optimizing Access to Non-occupational Post Exposure Prophylaxis for HIV Using Contingency Management in Stimulant-Using Men Who Have Sex With Men
Sponsor: Friends Research Institute, Inc.
A PHASE2 clinical study on HIV Seroconversion and Stimulant Abuse, this trial is completed. The trial is conducted by Friends Research Institute, Inc. and has accumulated 7 data snapshots since 2010. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
7 versions recorded-
Apr 2025 — Present [monthly]
Completed PHASE2
-
Sep 2024 — Apr 2025 [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE2
First recorded
May 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Friends Research Institute, Inc.
- University of California, Los Angeles
For direct contact, visit the study record on ClinicalTrials.gov .